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INTERNATIONAL NOTES
Pneumococcal Bacteremia in Adults over a 10-Year Period 
at University Hospital, Leiden
George A. W. Bruyn* Jos W. M. van der Meer, 
Jo Hermans, and Wilma Knopperl
From the Departments o f  Internal Medicine and Infectious 
Diseases and o f  Medical Statistics, University Hospital,
Leiden, The Netherlands
The medical records on all cases o f  pneum ococca l  bacteremia in adults  at the University 
Hospital ,  Leiden, over a 10-year period (1976-1986) were retrospectively reviewed. In this 
series o f  147 episodes (an annua l  incidence o f  0.8 episodes/10,000 adults),  overall m o r ta l ­
ity was 25.9%. Factors significantly related to a higher morta l i ty  rate were shock,  respira­
tory insufficiency, preexisting renal failure, and rapidly fatal underlying disease. Several 
labora tory  abnormali t ies  —such as a low percentage o f  band  forms, an elevated level o f  
serum lactate dehydrogenase, and hyperbilirubinemia —were significantly related to a poor  
outcome. Mult i lobar  pneum on ia  and  meningitis were both  associated w'ith high m o r ta l ­
ity, a l though  not to a statistically significant degree. Discriminant  analysis showed the 
presence o f  shock as the most powerful predictive factor o f  death.  Surprisingly, prior  
splenectomy did not correlate with higher mortality. Treatment with p-lactam antibiotics 
favorably influenced the ou tcom e o f  illness in patients with ult imately fatal and  nonfa ta l  
underlying disease, while the use o f  these agents in patients  w'ith rapidly fatal underlying 
disease did not  correlate significantly with a good prognosis.
The pneumococcus (Streptococcus pneumoniae) is 
one of the microorganisms most pathogenic for hu­
mans. Despite the advent of penicillin, the pneu­
mococcus has remained a major cause of disease. 
It is the foremost cause of community-acquired 
pneumonia and of bacterial meningitis in the elderly 
[1-4]. The latter infection still has a disturbingly high 
fatality rate.
In this paper, data are presented on the incidence 
of and the case-fatality rate for pneumococcal bac­
teremia in an adult population. These data are based 
on a retrospective analysis of records of patients from 
whose blood S. pneumoniae  was isolated. The aim 
of  this retrospective study was to discern risk fac-
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tors predictive of  a poor outcome in patients who 
present with pneumococcal bacteremia.
Patients and Methods
The records of adult patients from whose blood 
S. pneumoniae  was isolated between January 1976 
and January 1986 at the University Hospital, Leiden 
(UHL), were reviewed. UHL is a 900-bed hospital 
in which both general health care and all specialties 
are covered. Patients were identified by a search for 
cases of pneumococcal bacteremia in the computer­
ized registry of  the microbiology laboratory. A total 
of  147 episodes in 142 patients were found. The 
records of three patients could not be retrieved; how­
ever, since their age and sex and the outcome of their 
illness were known, their data were included in the 
calculation of incidence and mortality. One patient’s 
record provided insufficient data. Thus, a total of 
four patients were not included in further analyses.
Blood cultures were usually performed if the pa­
tient had fever (i.e., a rectal temperature of >38.5°C). 
Isolates of S. pneumoniae  were identified by stan­
dard laboratory techniques; isolates are not routinely 
typed in the Netherlands.
Episodes were categorized as community acquired 
(present on admission) or nosocomial (both the
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manifestation of  illness and positive blood cultures 
at least 3 days after admission). Meningitis was de­
fined by the isolation of S. pneumoniae  from CSF 
or the detection of pneumococcal antigen in CSF. 
Empyema was defined by the isolation of S. pneu­
moniae from pleural fluid. Endocarditis was defined 
by the criteria of Von Reyn et al. [5]. Arthritis was 
diagnosed clinically. The diagnosis of  pneumonia 
and sinusitis was in all cases confirmed by roent­
genography. Pneumococcal peritonitis was defined 
by the isolation of S. pneumoniae  from ascites. Re­
spiratory insufficiency was defined as a P a 0 2 of 
<7 kPa or a P a C 0 2 of >7 kPa. Shock was defined 
as systolic blood pressure less than 90 mm Hg in ad­
dition to other clinical signs of shock. Death was con­
sidered directly related to pneumococcal bacteremia 
when, as judged by clinical and pathologic criteria, 
the bacteremia was the prime cause.
The underlying disease of the patients was classi­
fied (according to McCabe and Jackson [6]) as rap­
idly fatal, ultimately fatal, or nonfatal. Blood counts 
and chemical tests were assessed on the SMA-12 mul­
tichannel autoanalyzer (Technicon, Tarrytown, N.Y.); 
data obtained on the day of the positive blood cul­
ture or the day thereafter were used in this analysis. 
Antimicrobial therapy was scored with regard to the 
choice of antibiotic.
Statistical analysis for comparison of two groups 
was performed by the x2 test for dichotomous vari­
ables and Student’s t test for continuous variables 
(sometimes after a logarithmic transformation). For 
identification of  the risk factors most predictive of 
a poor outcome of pneumococcal bacteremia, 10 
variables were studied: age, prior splenectomy, previ­
ous renal failure, underlying disease, chest roentgen- 
ographic abnormalities, origin of infection, menin­
gitis, shock, respiratory insufficiency, and antibiotic 
use. These variables were studied in cross-tabulations 
against death or survival with stepwise discriminant 
analysis [7].
Results
Characteristics o f  patients. Between January 
1976 and January 1986, 147 episodes of pneumo­
coccal bacteremia were registered at UHL, for an av­
erage of 14.7 episodes per year. For an estimated 
adult adherence population (a population calcula­
tion used by the Dutch government for hospitals with 
a large number of referrals, e.g., university hospi­
tals) of  180,000 patients per year, the annual inci­
dence of pneumococcal bacteremia is ^0 .8  cases/ 
10,000 adults. In terms of admissions (average, 17,335 
adults per year), the figures are indicative of 0.8 epi­
sodes/1,000 admissions.
The characteristics of the patients studied are sum­
marized in table 1. The mean age of the entire study
Table 1. Character is t ics  o f  patients  and  ou tcom e  o f  
143 episodes o f  pneum ococca l  bacteremia.
Median ± SD value (range) 
for indicated group*
Characteristic 
(unit of measure)
Nonfatal 
(n = 106)
Fatal 
(n = 37) P
Age (y) 58.5 ± 20.6 46.0 ± 20.2 .50
Sex (no. of  episodes) 
M
(15-91)
45
(20-92)
13
F 61 24 .55
Origin of infection 
(no. of episodes) 
Hospital 29 14 .32
Community 77 23
Duration of  illness 
before therapy (d) 2.0 ± 3.1 2.0 ± 6.9 .49
Temperature  (°C) 39.2 ± 0.8 39.0 ± 1.1 .62
Blood pressure 
(mm Hg) 
Systolic 1 2 0  ±  26 102 ± 33 < . 0 1
Diastolic 70 ± 18 70 ± 23 .15
Pulse (min-1) 115 ± 21 120 ± 25 .32
Symptoms (no. of 
episodes)t 
Chest pain 32 5 < . 0 2
Chills 34 4 .07
Leukocytes 
( x  109/L ) 10.6  ± 8.8 13.0 ± 9.2 .13
Band forms (%) 31 ± 22 2 2  ±  18 < . 0 2
Lactate dehydro­
genase (U/L) 176 ± 281 290 ± 1247 < . 0 0 1
Alkaline phospha­
tase (U/L) 95 ± 139 93 ± 8 6 .93
Erythrocyte sedi­
mentation rate 
( m m / l s t  h) 71 ± 39 6 6  ± 43 .60
Bilirubin (fimol/L) 15 ±  24 28 ± 1 1 0 < . 0 0 1
Sodium (mmol/L) 134 ± 5 133 ± 8 .40
* For some characteristics, only median values or median ± 
SD values are shown.
t  These data  concerned 140 episodes instead of  143.
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population was 52 years, with a range from 15 to 92 
years. O f  the 147 episodes, 69 (47%) occurred in 67 
patients over 60 years of  age. O f the 143 evaluatable 
bacteremic episodes, 58 occurred in male and 85 
in female patients (P < .01). In 43 episodes (30%) 
pneumococcal infection originated in the hospital, 
whereas in 100 episodes it was community acquired. 
Nosocomial pneumococcal infection was rare on the 
various surgical wards (n = 5) but was more frequent 
on the medical wards (n = 38). Pneumococcal bac­
teremia was secondary to pneumonia in 91 episodes. 
In the other 52 episodes, bacteremia was due to pneu­
mococcal infection outside the lung (in 24 cases, 
without an identifiable portal of  entry).
Underlying disease and splenectomy. The num ­
ber of  patients classified as having underlying dis­
ease is shown in table 2. The group classified as hav-
Table 2. Relations between potent ia l  risk factors  and  
o u tcom e  o f  pneum ococca l  bacteremia .
No. o f  episodes from indicated 
group with factor
Risk factor,
category (n
Total 
= 143)
Nonfatal 
(n = 106)
Fatal 
(n = 37) P*
Underlying diseaset
RFD 28 11 17
UFD 50 41 9 < . 0 0 1
NFD* 65 54 11
Splenectomy
Yes 15 13 2 .38
No 128 93 35
Preexisting renal failure 
Yes 8 1 7 < . 0 0 1
No 135 105 30
Preexisting 
hepatic failure 
Yes 5 3 2 .83
No 138 103 35
Chest roentgeno- 
graphic abnormality 
Pneumonia  only 80 56 24
Pneumonia  with 
complications 11 9 2 .43
Extrapulmonary
infection 52 41 11
* P  values pertain to differences between two groups —the non- 
fatal and the fatal.
t  RFD = rapidly fatal diseases; UFD = ultimately fatal dis­
ease; and NFD =  nonfatal  disease.
i  The NFD group included 11 patients with no known under­
lying diseases.
ing nonfatal underlying disease included 11 patients 
with no known underlying illnesses.
Fifteen episodes occurred in patients who had 
been splenectomized; the total number of  splenec­
tomies performed at this hospital in the 10-year 
period was 354. The interval between splenectomy 
and pneumococcal infection ranged from 3 days to 
34 years. In seven of  the 15 bacteremic episodes in 
splenectomized patients, primary bacteremia was 
present; i.e., no apparent portal o f  entry could be 
identified.
Complications. A wide range of complications 
occurred in a large number of patients. These events 
are summarized in table 3.
Treatment. Treatment with a (3-lactam antibiotic 
was considered appropriate. Thus, 129 episodes were 
treated appropriately. In nine of 14 episodes not 
treated with a (3-lactam antibiotic, drugs were with­
held for the following reasons: clinically insignifi­
cant bacteremia (two cases), terminal oncologic dis­
ease (five), and bacteremia occurring as a fulminant 
lethal event (two). In the other five o f  these 14 epi­
sodes, an aminoglycoside, a sulfonamide, trimetho- 
prim-sulfamethoxazole, or a tetracycline was given.
Outcome and analysis o f  risk factors. Bacterem­
ic episodes ended fatally in 38 cases; with a total of  
147 episodes, the overall mortality rate was 25.9%. 
With exclusion of the nine untreated cases, the cor­
rected mortality rate for treated pneumococcal bac­
teremia dropped to 22.5%. Analysis of the study pop­
ulation by decade of  age showed no significantly
Table 3. C o m p l ica t io n s  dur ing  143 episodes o f  p n e u ­
mococcal  bac te rem ia  and  o u tc o m e  o f  illness.
Complication
No. of  dea ths /  
no. o f  episodes
Complication Complication 
present absent p *
Multilobar pneumonia 15/38 22/105 .19
Empyema 2 / 1 1 35/132 .80
Arthritis 1/4 36/139 1.0
Endocardit is 1/5 36/138 1.0
Meningitis 7/15 30/128 .10
Shock 18/25 19/118 < . 0 0 1
Respiratory
insufficiency 8/15 29/128 < . 0 2
Cardiac arrhythmia 6/13 31/130 <.15
Peritonitis 1/1 36/142 <.58
* P  values pertain to differences in mortality between two 
groups —complication present and complication absent.
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poorer outcome for any decade. The relative number 
of deaths in male and female patients was also simi­
lar (table 1). O f a large number of clinical features, 
only a low systolic blood pressure and an absence 
of pleuritic chest pain were significantly related to 
mortality rate. Laboratory data analysis showed a 
significant association between a low percentage of 
band forms in the blood smear, a high serum level 
of  lactate dehydrogenase, and a high serum level of 
bilirubin on the one hand and a poor outcome on 
the other. As indicated in table 2, splenectomy proved 
not to be a significant risk factor. Rapidly fatal un ­
derlying disease was a highly significant risk factor 
for poor prognosis, as was preexisting renal failure 
(P < .001 for both). As indicated in table 3, shock 
and respiratory insufficiency were the only compli­
cations significantly related to a poor outcome (P
< .001 and P < .02, respectively). Complications 
proved to be additive in determining a poor outcome.
Despite the fact that all treated bacteremic epi­
sodes in patients with rapidly fatal underlying dis­
ease were treated with (3-lactam antibiotics, the fa­
tality rate was 60%. This outcome was significantly 
poorer than that for (3-lactam-treated patients with 
ultimately fatal or nonfatal underlying disease (P
< .001). Treatment of  the latter groups with (3-lactam 
agents resulted in mortality rates of  0 and 12%, 
respectively.
Stepwise discriminant analysis showed the most 
prognostic factors to be (in descending order) the 
presence of shock, the existence of rapidly fatal un­
derlying disease, the presence of meningitis, and the 
involvement of  multiple lobes. Analysis of these four 
variables yielded 32 correct predictions of  37 fatal 
outcomes (87%) and 87 correct predictions of 106 
nonfatal outcomes (82%).
Discussion
In this retrospective study o f  147 episodes of pneu­
mococcal bacteremia, the case-fatality rate was 
25.9% for all episodes and 22.5% of episodes treated 
with antibiotics. Patients with rapidly fatal under­
lying disease had a poor prognosis if they manifested 
pneumococcal bacteremia. Apart  from rapidly fa­
tal underlying disease, a number of other risk fac­
tors were found, including preexisting renal failure, 
presence of shock, presence of  respiratory insuffi­
ciency, absence of  pleuritic chest pain, low number 
of  band forms, and elevated serum levels o f  lactate
dehydrogenase and bilirubin. In these respects our 
results are similar to those of studies from other 
countries during the antibiotic era [8-16]. As the 
most powerful predictive factors of a poor outcome 
of illness, we found first of all the presence of shock, 
which was followed in significance by rapidly fatal 
underlying disease, the presence of meningitis, and 
multilobar pneumonia.
Some divergence from prior studies exists, how­
ever. First, we did not find increased mortality with 
advanced age [8, 17]. A partial explanation could 
be that in our study many relatively young patients 
(under 50 years of  age) had rapidly fatal underlying 
disease. Another factor of possible influence is that 
elderly patients may currently tend to seek medical 
attention more promptly than in previous years [18]. 
Second, we did not find a significantly higher mor­
tality among patients with nosocomial bacteremia 
than among those with community-acquired bacter­
emia; this result is in contrast to those of recent 
studies of  veterans [19]. Third, an intriguing obser­
vation not previously made is that pneumococcal 
bacteremia occurred significantly more frequently 
in women than in men. However, case-fatality rates 
were similar for the two sexes. Fourth, mortality 
among splenectomized persons at U H L  was only 
0.6%, whereas Singer [20], in his study of more than 
2,795 splenectomized persons, reported a much 
higher mortality rate of  2.52%. This difference in 
death rate cannot be explained by a higher degree 
of  vaccination in our group, since only one of  the 
splenectomized persons had been vaccinated before 
developing pneumococcal bacteremia. One hypoth­
esis is that in a small country like the Netherlands 
these patients are able to seek medical attention at 
a comparatively early stage, resulting in prompt 
treatment.
In our series, appropriate therapy did not have an 
effect on the course of  illness in patients who were 
particularly at risk —i.e., those with rapidly fatal un­
derlying disease. This observation confirms the im­
portance of  underlying disease in the treatment and 
outcome of  infections [6]. It also emphasizes the ur­
gent need for specific preventive measures in this 
high-risk group.
In conclusion, our study shows no major geo­
graphic differences with regard to the incidence, out­
come, or clinical picture of pneumococcal bacter­
emia. However, some points of  divergence with prior 
studies exist; these discrepancies may be related to 
country size, patient population, and other factors.
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